Table 2.
Clinical feature | Influenza negative N = 173 n (%) | Influenza positive N = 21 n (%) | P value |
---|---|---|---|
Contact in last 7 days | 64 (37) | 14 (67) | 0·009 |
Nasal discharge on examination | 44 (25) | 13 (62) | 0·0005 |
Fever | 136 (79) | 17 (81) | 0·80 |
Chills | 113 (65) | 17(81) | 0·15 |
Rigors | 36 (21) | 7 (33) | 0·19 |
Cough | 141 (82) | 18 (86) | 0·63 |
Sputum production | 101 (58) | 13 (62) | 0·76 |
Sore throat | 57 (33) | 8 (38) | 0·64 |
Nasal discharge | 103 (60) | 16 (76) | 0·14 |
Nasal stuffiness | 81 (47) | 14 (67) | 0·08 |
Body ache | 115 (67) | 12 (57) | 0·39 |
Malaise | 40 (23) | 5 (24) | 1·00 |
Vomiting | 25 (14) | 3 (14) | 1·00 |
Breathlessness | 96 (56) | 15 (71) | 0·16 |
Current smoker | 59 (34) | 5 (24) | 0·34 |
Respiratory cases at home | 37 (21) | 7 (33) | 0·21 |
Underlying OAD | 45 (26) | 6 (29) | 0·80 |
Cyanosis | 41 (24) | 2 (10) | 0·17 |
Accessory muscle usage | 52 (30) | 11(52) | 0·04 |
Crepitations | 68 (39) | 8 (38) | 0·91 |
Rhonchi/Wheeze | 48 (28) | 6 (29) | 0·94 |
Hepatomegaly | 16 (9) | 2(10) | 1·00 |
Pneumonia/Infiltrates on radiograph | 53 (31) | 9 (43) | 0·25 |
Duration of symptoms (mean days, range) | 5·31 + 2·91 (1–15) | 4·81 ± 2·97 (1–15) | 0·67 |